[
    [
        {
            "time": "",
            "original_text": "华熙生物董事长赵燕：让健康之美说话 做国人自豪世界尊重的企业",
            "features": {
                "keywords": [
                    "华熙生物",
                    "董事长",
                    "赵燕",
                    "健康之美",
                    "企业形象"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药",
                    "消费品"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "华熙生物董事长赵燕：让健康之美说话 做国人自豪世界尊重的企业",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "华熙生物：已经关注并开始研发玻尿酸在胃肠黏膜、计生等领域的应用",
            "features": {
                "keywords": [
                    "华熙生物",
                    "玻尿酸",
                    "胃肠黏膜",
                    "计生",
                    "研发"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药",
                    "医疗健康"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "华熙生物：已经关注并开始研发玻尿酸在胃肠黏膜、计生等领域的应用",
                "Correlation": 10,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "华熙生物董事长：公司推出了国内首款以玻尿酸为基质的消杀产品",
            "features": {
                "keywords": [
                    "华熙生物",
                    "董事长",
                    "玻尿酸",
                    "消杀产品",
                    "国内首款"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药",
                    "消费品",
                    "防疫产品"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "华熙生物董事长：公司推出了国内首款以玻尿酸为基质的消杀产品",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "华熙生物科技集团股份有限公司",
            "features": {
                "keywords": [
                    "华熙生物",
                    "科技",
                    "集团",
                    "股份有限公司"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药",
                    "科技"
                ],
                "causal_factor": "false",
                "causal_impact": "",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "华熙生物科技集团股份有限公司",
                "Correlation": 5,
                "Sentiment": 5,
                "Importance": 3,
                "Impact": 2,
                "Duration": 2,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 6,
                "Headline_Structure": 3,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "华熙生物董事长：希望将“润百颜”打造成全球玻尿酸第一品牌",
            "features": {
                "keywords": [
                    "华熙生物",
                    "董事长",
                    "润百颜",
                    "玻尿酸",
                    "全球第一品牌"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药",
                    "消费品"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "华熙生物董事长：希望将“润百颜”打造成全球玻尿酸第一品牌",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "华熙生物董事长：目前公司拥有微生物发酵和交联两大技术平台",
            "features": {
                "keywords": [
                    "华熙生物",
                    "董事长",
                    "微生物发酵",
                    "交联技术",
                    "技术平台"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药",
                    "技术研发"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "华熙生物董事长：目前公司拥有微生物发酵和交联两大技术平台",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        }
    ]
]